CD1d is expressed on B-chronic lymphocytic leukemia cells and mediates alpha-galactosylceramide presentation to natural killer T lymphocytes.
D017951:Antigen Presentation; D018949:Antigens, CD1 / Q000378:metabolism*; D000945:Antigens, Differentiation, T-Lymphocyte / Q000032:analysis; D002455:Cell Division; D015331:Cohort Studies; D005434:Flow Cytometry; D005699:Galactosylceramides / Q000276:immunology*; D006801:Humans; D007135:Immunoglobulin Variable Region / Q000235:genetics; D007371:Interferon-gamma / Q000378:metabolism; D007694:Killer Cells, Natural / Q000276:immunology*; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000276:immunology* / Q000473:pathology; D013601:T-Lymphocytes / Q000276:immunology*; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
D018949:Antigens, CD1; D000945:Antigens, Differentiation, T-Lymphocyte; D005699:Galactosylceramides; D007135:Immunoglobulin Variable Region; D014409:Tumor Necrosis Factor-alpha; D007371:Interferon-gamma